Consun Pharmaceutical Group Limited (1681.HK)

HKD 7.63

(-1.68%)

Operating Income Summary of Consun Pharmaceutical Group Limited

  • Consun Pharmaceutical Group Limited's latest annual operating income in 2023 was 884.96 Million CNY , up 23.7% from previous year.
  • Consun Pharmaceutical Group Limited's latest quarterly operating income in 2024 Q2 was 447.33 Million CNY , down 0.0% from previous quarter.
  • Consun Pharmaceutical Group Limited reported an annual operating income of 715.4 Million CNY in 2022, up 8.37% from previous year.
  • Consun Pharmaceutical Group Limited reported an annual operating income of 660.18 Million CNY in 2021, up 20.01% from previous year.
  • Consun Pharmaceutical Group Limited reported a quarterly operating income of 884.96 Million CNY for 2023 FY, up 23.7% from previous quarter.
  • Consun Pharmaceutical Group Limited reported a quarterly operating income of 500.15 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Income Chart of Consun Pharmaceutical Group Limited (2023 - 2012)

Historical Annual Operating Income of Consun Pharmaceutical Group Limited (2023 - 2012)

Year Operating Income Operating Income Growth
2023 884.96 Million CNY 23.7%
2022 715.4 Million CNY 8.37%
2021 660.18 Million CNY 20.01%
2020 550.12 Million CNY 10.83%
2019 496.37 Million CNY -24.25%
2018 655.32 Million CNY 22.85%
2017 533.43 Million CNY 33.88%
2016 398.45 Million CNY 35.56%
2015 293.92 Million CNY 24.83%
2014 235.46 Million CNY 14.39%
2013 205.83 Million CNY 13.7%
2012 181.02 Million CNY 0.0%

Peer Operating Income Comparison of Consun Pharmaceutical Group Limited

Name Operating Income Operating Income Difference
Pak Fah Yeow International Limited 143.01 Million HKD -518.806%
Grand Pharmaceutical Group Limited 2.66 Billion HKD 66.773%
Extrawell Pharmaceutical Holdings Limited -8.16 Million HKD 10942.526%
Wai Yuen Tong Medicine Holdings Limited 40.88 Million HKD -2064.792%
Qianhai Health Holdings Limited -52.18 Million HKD 1795.891%
Lee's Pharmaceutical Holdings Limited 36.04 Million HKD -2355.377%
Essex Bio-Technology Limited 310.32 Million HKD -185.17%
Tongfang Kontafarma Holdings Limited - HKD -Infinity%
PuraPharm Corporation Limited -66.04 Million HKD 1439.925%
SSY Group Limited 1.63 Billion HKD 46.002%
JBM (Healthcare) Limited 174.2 Million HKD -408.003%
Jacobson Pharma Corporation Limited 333.12 Million HKD -165.655%
China Resources Pharmaceutical Group Limited 12.14 Billion HKD 92.715%